+351 211 369 829 INFO@OPHIOMICS.COM

Ophiomics is growing! We are very happy to have onboard new team members that bring expertise in strategic fields. 

Our team will be focused on developing HepatoPredictA decision tool for Liver Transplantation based on molecular signature, that has recently been awarded funding by the program EIC Accelerator. 

Welcome!
Sara
Diana
Maria
André
Filipa

Share the Post:

Related Posts

Thinking Big!

Ophiomics is now participating in the IPOready program by Euronext. This is a great opportunity to consider the best strategy

Read More